CLX vs REYN: Which Is the Better Buy in 2026?

Same yardstick, side by side (as of October 2026). Valuation lined up like this is most meaningful for two names in the same corner of the market, which these are. Figures are approximate; verify before investing.

The metrics above tell you which is the marginally better business. The bigger risk for most people is not picking the slightly worse stock, it is over-concentrating. CLX and REYN share themes, so owning both, or adding either to what you already hold, can quietly push a large share of your portfolio into one bet.

This is the part a generic comparison page cannot answer, because it depends on what you own. Connect your brokerage and Walnut shows your real, combined CLX and REYN exposure, flags overlap with your existing positions, and tells you if adding one would tip you past a concentration you are comfortable with, read-only by default, with your login staying at your broker. Walnut is not an investment adviser.

The Clorox Company is a US consumer-staples business that sells everyday household and personal-care products through four segments: Health and Wellness (Clorox cleaning and disinfecting, professional products, plus vitamins and supplements), Household (Glad bags and wraps, Kingsford charcoal, Fresh Step and Scoop Away cat litter), Lifestyle (Hidden Valley dressings, Brita water filtration, Burt's Bees natural personal care), and International. Because these are low-cost, repeat-purchase staples, demand is relatively stable across economic cycles, which is why Clorox has long been treated as a defensive holding and a dividend aristocrat with decades of consecutive annual increases.

Full CLX guide

Reynolds Consumer Products Inc. makes and sells household staples used in cooking, cleanup, food storage, and entertaining. Its products reach roughly 95% of U.S. homes through iconic brands including Reynolds Wrap aluminum foil, Reynolds Kitchens parchment and plastic wrap, Hefty trash and storage bags, and Hefty disposable plates, cups, and cutlery. The company reports in four segments: Reynolds Cooking and Baking, Hefty Waste and Storage, Hefty Tableware, and Presto Products (a leading private-label supplier). Because it sells low-priced, frequently-repurchased consumables, demand is relatively defensive, but the categories are mature and heavily contested by both branded competitors and retailer private-label programs.

Full REYN guide

Both fit overlapping themes, but they are not interchangeable. The useful comparison is which set of drivers and risks you want exposure to.

• CLX drivers: Defensive staple with durable brands; ERP transition moving from cost to benefit.
• REYN drivers: Defensive, everyday-staple demand; Margin recovery and productivity.

A faster-growing, richer-valued name usually swings harder, so it suits a longer horizon and a higher tolerance for volatility; a steadier, more cash-generative business suits a more conservative or income-minded investor. The honest test is which set of risks you could hold through a drawdown: The near-term risk is execution: the ERP transition already caused lost market share and a guided net-sales decline, and any further disruption or slow recovery of shelf presence would delay the rebound. For REYN, the dominant risk is input-cost volatility: aluminum for foil and resin for bags and tableware are large costs that can compress margins quickly when prices rise, and tariffs on aluminum add further uncertainty.

Growth-minded investors who believe the theme has years to run tend to accept the richer multiple for more upside; value-minded investors lean toward the cheaper forward earnings and steadier profile. Pick CLX if you believe its drivers more; REYN if you believe its. Many investors hold both, but since they share themes, that is a concentrated bet, not diversification. Decide deliberately and check overlap. For the full detail, see the CLX and REYN guides.

CLX. Clorox reports on a fiscal year ending in June, and recent results are distorted by ERP-transition shipment timing, so headline growth comparisons can mislead. At about 18 times trailing and 14 times forward earnings with a 5.8% yield as of October 16, 2026, the stock is priced well below its historical staples premium, and the 17-analyst mean target of about $97 sits above the $87.21 close with a consensus of hold, although several targets were cut in October. Debt of about $5.6 billion and a payout above 100% of earnings are the figures to watch alongside the margin recovery.

REYN. Figures are approximate and tied to the asOf date; verify live numbers before acting. At $22.65 Reynolds trades at about 1.3 times sales and near 13 to 14 times trailing and forward earnings, a valuation that reflects the market pricing it as a slow-growing income staple rather than a growth name. The shares fell about 12% over three months, and UBS cut its target to $24 from $27 on October 15, 2026 while keeping a Neutral rating; the seven-analyst mean target sits near $26.29. Consensus for the November 4 report is about $0.38 per share.

Headline figures (approximate, October 2026): CLX shows net sales (fy2026, ended june) ~$6.72 billion (down ~5% from ~$7.10 billion), net income (fy2026) ~$587 million (vs ~$810 million in FY2025), fiscal q4 2026 adjusted eps $1.66 vs $1.65 estimate, margins (ttm) ~42% gross, ~13% operating; REYN shows revenue (ttm) ~$3.79 billion (Q2 2026 ~$944 million, up ~0.6%), net income (ttm) ~$344 million (~9% net margin), eps Q2 2026 ~$0.42 vs ~$0.40 est.; trailing ~$1.64, fy2026 guidance (adjusted ebitda, as of q1) ~$660 million to ~$675 million; EPS ~$1.57 to ~$1.63.

CLX and REYN are related but distinct: same themes, different businesses and risks. Neither wins in the abstract; the right pick is whichever thesis you actually believe, sized so you are not over-concentrated in one theme. Walnut can show your combined CLX and REYN exposure against your real portfolio. It is not an investment adviser.